Abstract
Many studies have examined the association between the VEGF +936C/T (rs833061) and +460C/T (rs3025039) gene polymorphisms and oral cancer risk in various populations, but their results have been inconsistent. To assess this relationship more precisely, we performed a meta-analysis. The PubMed, Embase, Web of Science, and China National Knowledge Infrastructure databases were searched for case–control studies that were published up to January 2013. Data were extracted and pooled odds ratios (ORs) with 95 % confidence intervals (CIs) were calculated. Ultimately, six studies were included, comprising 1006 oral cancer cases and 1016 controls. Overall, the pooled OR for VEGF +936 T allele carriers (TC + TT) versus the wild-type homozygotes (CC) was 1.28 (95 % CI 1.04–1.58; P = 0.228 for heterogeneity), the pooled OR for TT versus CC was 1.64 (95 % CI 1.34–1.98; P = 0.315 for heterogeneity), and the pooled OR for the T allele versus the C allele was 1.42 (95 % CI 1.22–1.76; P = 0.286 for heterogeneity). In the stratified analysis by ethnicity, significant risks were found among Caucasians but not Asians. However, there were no associations between VEGF +460C/T and oral cancer risk in only two of the included studies. In conclusion, this meta-analysis demonstrates that the VEGF +936 T allele may be associated with an increased risk of oral cancer, especially among Caucasian populations.
Similar content being viewed by others
References
Zygogianni AG, Kyrgias G, Karak itsos P, Psyrri A, Kouvaris J, Kelekis N, Kouloulias V (2011) Oral squamous cell cancer: early detection and the role of alcohol and smoking. Head Neck Oncol 3:2
Reichart PA, Nguyen XH (2008) Betel quid chewing, oral cancer and other oral mucosal diseases in Vietnam: a review. J Oral Pathol Med 37:511–514
Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4–25
Zhan P, Wang J, Lv XJ, Wang Q, Qiu LX, Lin XQ, Yu LK, Song Y (2009) Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis. J Thorac Oncol 4(9):1094–1103
Chae YS, Kim JG, Sohn SK, Cho YY, Moon JH, Bae HI, Park JY, Lee MH, Lee HC, Chung HY, Yu W (2006) Investigation of vascular endothelial growth factor gene polymorphisms and its association with clinicopathologic characteristics in gastric cancer. Oncology 71:266–272
Dassoulas K, Gazouli M, Rizos S, Theodoropoulos G, Christoni Z, Nikiteas N, Karakitsos P (2009) Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog 48:563–569
Stevens A, Soden J, Brenchley PE et al (2003) Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 63:812–816
Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101–129
Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
Tobias A (1999) Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 8:15–17
Egger M (1997) Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 315:629–634
Supic G, Jovic N, Zeljic K, Kozomara R, Magic Z (2012) Association of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patients. Oral Oncol 48(11):1171–1177
Lin YC, Yeh CJ, Wang LH, Lee CW, Chen CH (2012) The effect of CCND1 +870A > G and VEGF +936C > T polymorphisms on oral cancer development and disease-free survival in a Taiwan population. Oral Oncol 48(6):535–540
Kämmerer PW, Toyoshima T, Eletr S, Kämmerer P, Kuhr K, Al-Nawas B, Brieger J (2010) Single nucleotide polymorphisms of the vascular endothelial growth factor gene associated with incidence of oral squamous cell carcinoma. J Oral Pathol Med 39(10):786–792
Cheng CY, Chang CS, Liu CJ, Kao SY (2008) Vascular endothelial growth factor 936 C/T polymorphism is associated with vascular invasion in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106(1):79–84
Yapijakis C, Vairaktaris E, Vassiliou S, Vylliotis A, Nkenke E, Nixon AM, Derka S, Spyridonidou S, Vorris E, Neukam F, Patsouris E (2007) The low VEGF production allele of the +936C/T polymorphism is strongly associated with increased risk for oral cancer. J Cancer Res Clin Oncol 133(10):787–791
Ku KT, Wan L, Peng HC, Tsai MH, Tsai CH, Tsai FJ (2005) Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for oral cancer. Oral Oncol 41(5):497–502
Kämmerer PW, Koch FP, Schiegnitz E, Kumar VV, Berres M, Toyoshima T, Al-Nawas B, Brieger J (2012) Associations between single-nucleotide polymorphisms of the VEGF gene and long-term prognosis of oral squamous cell carcinoma. J Oral Pathol Med 10
Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182–1186
Yu L, Deng L, Li J, Zhang Y, Hu L (2013) The prognostic value of vascular endothelial growth factor in ovarian cancer: a systematic review and meta-analysis. Gynecol Oncol 128(2):391–396
Eng L, Azad AK, Habbous S, Pang V, Xu W, van der Maitland- Zee AH, Savas S, Mackay HJ, Amir E, Liu G (2012) Vascular endothelial growth factor pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a systematic review and meta-analysis. Clin Cancer Res 18(17):4526–4537
Peng L, Zhan P, Zhou Y, Fang W, Zhao P, Zheng Y, Xu N (2012) Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis. Mol Biol Rep 39(10):9473–9484
Chen M, Cai E, Huang J, Yu P, Li K (2012) Prognostic value of vascular endothelial growth factor expression in patients with esophageal cancer: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 21(7):1126–1134
McCarron SL, Edwards S, Evans PR, Gibbs R, Dearnaley DP, Dowe A, Southgate C, Easton DF, Eeles RA, Howell WM (2002) Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res 62:3369–3372
Hirschhorn JN, Lohmueller K, Byrne E (2002) A comprehensive review of genetic association studies. Genet Med 4:45–61
Cao C, Fang JJ, Ying T, Sun SF, Lv D, Chen ZB, Ma HY, Yu YM, Ding QL, Shu LH, Deng ZC (2010) Vascular endothelial growth factor +936C/T and +405G/C polymorphisms and cancer risk: a meta-analysis. Arch Med Res 41(7):548–557
Zhuo W, Wang Y, Zhuo X, Zhu Y, Wang W, Zhu B, Li D, Chen Z (2009) CYP1A1 and GSTM1 polymorphisms and oral cancer risk: association studies via evidence-based meta-analyses. Cancer Invest 27:86–95
Zhou C, Zhou Y, Li J, Zhang Y, Jiang L, Zeng X, Feng X, Wang Z (2009) The ARG 194TRP poly morphism in the X –ray repair cross complementing group 1 gene as a potential risk fact or of oral cancer: a meta-analysis. Tohoku J Exp Med 219:43–51
Niu Y, Hu Y, Wu M, Jiang F, Shen M, Tang C, Chen N (2012) CYP2E1 Rsa I/Pst I polymorphism contributes to oral cancer susceptibility: a meta-analysis. Mol Biol Rep 39:607–612
Zhuo XL, Li Q, Zhou Y, Cai L, Xiang ZL, Yuan W, Zhang XY (2009) Study on TP53 codon 72 poly morphisms with oral carcinoma susceptibility. Arch Med Res 40:625–634
Zhan P, Wang Q, Qian Q, Wei SZ, Yu LK (2011) CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review. J Exp Clin Cancer Res 20(30):99
Zhan P, Wang Q, Wei SZ, Wang J, Qian Q, Yu LK, Song Y (2010) ERCC2/XPD Lys751Gln and Asp312Asn gene polymorphism and lung cancer risk: a meta-analysis involving 22 case-control studies. J Thorac Oncol 5(9):1337–1345
Zhan P, Wang J, Zhang Y, Qiu LX, Zhao SF, Qian Q, Wei SZ, Yu LK, Song Y (2010) CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians. Lung Cancer 69(1):19–25
Wu Y, Liu HB, Ding M et al (2012) The impact of E-cadherin expression on non-small cell lung cancer survival: a meta-analysis. Mol Biol Rep 39:9621–9628
Qian Q, Wang Q, Zhan P et al (2010) The role of matrix metalloproteinase 2 on the survival of patients with non-small cell lung cancer: a systematic review with meta-analysis. Cancer Invest 28:661–669
Zhan P, Qian Q, Yu LK (2013) Prognostic value of COX-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis. J Thorac Dis 5:40–47
Zhan P, Qian Q, Wan B, Yan TD, Yu LK (2013) Prognostic value of TTF-1 expression in patients with non-small cell lung cancer: a meta-analysis. Transl Cancer Res. doi:10.3978/j.issn.2218-676X.2013.02.08
Miao XH, Yao YW, Yuan DM et al (2012) Prognostic value of the ratio of ground glass opacity on computed tomography in small lung adenocarcinoma: a meta-analysis. J Thorac Dis 4:265–271
Zhang ZJ, Hao K, Shi R, Zhao G, Jiang GX, Song Y, Xu X, Ma J (2011) Glutathione S-transferase m1 (GSTM1) and glutathione S-transferase t1 (GSTT1) null polymorphisms, smoking, and their interaction in oral cancer: a huge review and meta-analysis. Am J Epidemiol 173:847–857
Conflict of interest
The authors declare no conflicts of interest in this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhao, SF., Zhan, P., Yang, XD. et al. VEGF +936C/T and +460C/T gene polymorphisms and oral cancer risk: a meta-analysis. Mol Biol Rep 40, 6637–6643 (2013). https://doi.org/10.1007/s11033-013-2778-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-013-2778-x